U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07718139) titled 'Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and Canada' on July 10.
Brief Summary: This study uses existing medical records to better understand how immunotherapy is used in people in Europe and Canada with non-small cell lung cancer (NSCLC) who undergo surgery. It looks at participant characteristics, treatments received before and after surgery, and outcomes such as survival.
Study Start Date: Feb. 28
Study Type: OBSERVATIONAL
Condition:
Non-Small Cell Lung Cancer
Intervention:
BIOLOGICAL: nivolumab
As per product label
BIOLOGICAL: pe...